National Bank of Greece S.A. (ATH:ETE)

CTI BioPharma Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 8, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	11,883	6,981	5,753	3,427	2,681	2,067
Market Cap Growth	38.65%	21.36%	67.84%	27.82%	29.75%	-25.17%
Last Close Price	13.07	7.34	5.76	3.43	2.69	2.07
PE Ratio	10.84	6.03	5.20	3.06	3.09	62.63
PS Ratio	4.52	2.58	2.28	1.62	1.46	1.44
PB Ratio	1.35	0.83	0.75	0.53	0.47	0.41
P/FCF Ratio	321.17	-	-	171.37	1.33	0.33
P/OCF Ratio	41.70	-	-	16.09	1.22	0.32
Debt / Equity Ratio	0.62	0.72	0.91	2.09	3.22	3.34
Debt / FCF Ratio	147.89	-	-	676.85	9.20	2.74
Return on Equity (ROE)	12.92%	14.42%	15.70%	14.57%	14.44%	7.74%
Return on Assets (ROA)	1.46%	1.55%	1.45%	1.10%	0.97%	0.57%
Earnings Yield	9.25%	16.59%	19.23%	32.68%	32.33%	1.60%
FCF Yield	0.31%	-45.19%	-124.78%	0.58%	75.37%	300.20%
Dividend Yield	2.79%	-	6.25%	-	-	-
Payout Ratio	67.06%	28.67%	-	-	-	-
Buyback Yield / Dilution	-0.14%	0.26%	0.01%	-0.01%	-0.01%	-0.00%
Total Shareholder Return	2.68%	0.26%	6.25%	-0.01%	-0.01%	-0.00%

Updated Mar 15, 2025. Source: S&P Global Market Intelligence. Banks template. Financial Sources.